Innovent Biopharmaceutical Transformation
A Clear Strategy to Become a World Class
Biopharmaceutical Company
Continue expansion of
commercial portfolio and
performance
☐
☐
Over a dozen of late stage pipeline
Rmb 20bn sales potential for China late stage
pipeline in 5 years
0
Driven by
innovation,
developed
through
globalization
Expand business to include
more global development
for clinical assets
Internally focus on 7 major
research taskforces to
deliver global potential
drugs
Leverage BD to empower
internal R&D and fuel
globalization
◉
◉
◉
PoC for four clusters of global assets ongoing
and more to come
Established global development platform
80+ Innovent Academy Projects
Proprietary technology platforms
Goal to deliver multiple global potential
assets each year
☐
Strengthen technical core-competency
☐
Strengthen global product portfolio
☐
Going from domestic to global market
Innovent
Confidential
Copyright©2022 Innovent
14View entire presentation